| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lucira Health, Inc. | Chief Financial Officer | Common Stock | 77,910 | 07 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals, Inc. | 13 Sep 2023 | 0 | $0 | 3 | Interim CFO | 19 Sep 2023, 17:05 |
| /report/000120919123018225-narido-richard-clavano-2023-03-03 | Lucira Health, Inc. | 03 Mar 2023 | 5 | -$29,423 | 4 | Chief Financial Officer | 13 Mar 2023, 17:10 |
| /report/000120919122059999-narido-richard-clavano-2022-12-01 | Lucira Health, Inc. | 01 Dec 2022 | 1 | -$570 | 4 | Interim CFO | 06 Dec 2022, 15:21 |
| /report/000195605022000002-narido-richard-clavano-2022-11-15 | Lucira Health, Inc. | 15 Nov 2022 | 0 | $0 | 3 | Interim CFO | 25 Nov 2022, 17:14 |